As shown in Figure 5A,B (whole blot included in Figure S4B), ICG-001 treatment could reduce the expression of ITGB1 in NPC C666-1, HK-1, and HONE-1 cells. Here, ITGB1 is linked to nasopharyngeal carcinoma.